<DOC>
	<DOCNO>NCT00579345</DOCNO>
	<brief_summary>The study primarily aim evaluate immunogenicity safety influenza vaccine ( cell culture derive seasonal trivalent influenza vaccine ( cTIV ) influenza virus vaccine ( egg-derived seasonal trivalent , thiomersal free ; eTIV_a ) ) administer alone administer concomitantly pneumococcal polysaccharide vaccine ( PV ) elderly subject . The study also aim evaluate safety immunogenicity ( subset ) annual vaccination either cTIV eTIV_a adult elderly subject .</brief_summary>
	<brief_title>Second Extension Study Evaluate Safety Tolerability Influenza Vaccines Adults Elderly , Evaluate Immunogenicity Concomitant Vaccination With Pneumococcal Vaccine Subgroup</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>participation V58P4 study mentally competent understand nature , scope consequence study able willing give write informed consent prior study entry available visit schedule study receipt another investigational agent within 90 day prior , completion safety followup period another study , whichever longer , prior Visit 7 unwilling refuse participation another clinical study end present study history anaphylaxis , serious vaccine reaction , allergy vaccine component acute respiratory disease infection require systemic antibiotic antiviral therapy ( chronic antibiotic therapy urinary tract prophylaxis acceptable ) experience fever ( i.e. , axillary temperature ≥ 38°C ) within 5 day prior Visit 7 pregnant/breast feeding woman , woman childbearing potential refuse use reliable contraceptive method three week vaccination</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
</DOC>